Stockreport

Albireo Reports Third Quarter 2019 Financial Results and Provides Business Update

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF — Phase 3 PFIC trial randomization more than three-quarters complete. —— Topline results expected mid-2020. —— Pivotal trial in biliary atresia expected to be initiated [Read more]